Premium
Growth inhibition of BEL‐7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase
Author(s) -
Zhang Rugang,
Wang Xingwang,
Guo Lixia,
Xie Hong
Publication year - 2001
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.1597
Subject(s) - telomerase reverse transcriptase , reverse transcriptase , mutant , telomerase , biology , microbiology and biotechnology , virology , genetics , rna , gene
Human hepatocellular carcinoma (HCC) is one of the most common malignancies in Asia and Africa. Human telomerase reverse transcriptase (hTERT) is expressed in HCC but absent in normal human liver cells, which is consistent with the expression pattern of telomerase. In the present study, expression of a dominant‐negative form of hTERT (DN‐hTERT) resulted in inhibition of telomerase activity and decreased mean telomeric length of BEL‐7404 human hepatoma cells, whereas expression of wild‐type hTERT (WT‐hTERT) and control vector had no such effects. Cell growth was inhibited by this mutant (DN‐hTERT), which was consistent with the changes in telomerase level. Flattened large cells were found in late generations with the DN‐hTERT treatment. When mean telomeric length of DN‐hTERT–transfected cells reached a critical length (about 1.7 kb), apoptosis was induced. Tumorigenicity of DN‐hTERT–expressing cells was eliminated in vivo. These data indicated that hTERT was essential for the growth of hepatoma cells. hTERT can also be used as an important target for anti‐HCC drug screening. © 2002 Wiley‐Liss, Inc.